Test Price
3,000 AED✅ Home Collection Available
NCL Enzyme Panel Genetic Test in UAE | 3000 AED | DHA-Accredited
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance by DHA‑Licensed Consultant Medical Genetics (Ms. Lina Osama Zaki Quteineh, DHA 9294403).
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This service strictly adheres to UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The NCL Enzyme Panel Genetic Test screens for pathogenic variants in genes associated with Neuronal Ceroid Lipofuscinoses (NCL), a group of inherited metabolic disorders. This advanced next‑generation sequencing assay identifies causative mutations with high accuracy, aiding in diagnosis, carrier detection, and family planning.
| Feature | Our NGS Panel Test | Traditional Biochemical Enzyme Assay |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity; comprehensive mutation detection | Variable sensitivity; limited to enzyme activity, cannot identify all genetic subtypes |
| Methodology | Next‑Generation Sequencing (NGS) of full coding regions and splice sites | Fluorometric / spectrophotometric enzyme activity measurement |
| Turnaround Time | 3 to 4 Weeks | 2 to 3 Weeks (but often requires additional confirmatory genetic testing) |
Physician Insight & Safety Protocols
“Dear patient, I urge you to interpret these genetic test results in collaboration with your healthcare provider; a positive finding does not always predict symptom severity, and a negative result does not exclude all NCL forms. This test is a powerful tool for informed decisions, but it is only one piece of your complete clinical picture. Please do not discontinue any prescribed medication without consulting your doctor.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Advisory & Safety Notice
- Do not discontinue or alter any prescribed medication without consulting your physician.
- This genetic test is intended for diagnostic and carrier screening; it does not replace clinical evaluation.
- A negative result does not rule out all forms of NCL; a positive result may require further family studies.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (or guardian consent for minors).
- Known active sepsis, gross hemolysis, or insufficient sample (contact our team for re‑collection).
- Acute febrile illness requiring postponement of non‑urgent blood draw.
- ER Red Flag: If sudden vision loss, uncontrolled seizures, or rapid neurological decline occurs, seek emergency care immediately – these may indicate disease progression unrelated to the test procedure.
Patient FAQ & Clinical Guidance
1. What is the NCL Enzyme Panel Genetic Test?
This test uses next‑generation sequencing to analyse the full coding regions of NCL‑associated genes, detecting single nucleotide variants and small insertions/deletions linked to Batten disease and related disorders. It provides a definitive molecular diagnosis and is essential for genetic counselling.
2. How should I prepare for the test?
No fasting is required; simply provide a blood sample (or an FTA card spot), but you must complete a genetic counselling session to document your family history. This session ensures the targets the most relevant genes and that you fully understand the implications.
3. How long does it take to get results?
Results are typically available within 3 to 4 weeks due to the comprehensive sequencing and interpretive analysis required for high‑accuracy reporting. You will be notified via WhatsApp as soon as the report is finalised, and a tele‑consultation can be scheduled.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
This service strictly adheres to the UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled under the highest standards of confidentiality and security, with consent protocols in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | NCL Enzyme Panel Genetic Test |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or FTA Blood Spot Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Coding Regions & Splice Sites |
| ICD-10-CM Code | E75.4 (Neuronal ceroid lipofuscinosis) |
| LOINC Code | 101259-2 (NCL gene mutation panel) |
| DHA Facility License & Laboratory Address | License Number: DHA‑1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians